The study found that the expression level of MFN2 protein decreased significantly in NASH patients, liver steatosis mice and NASH mice; another study found that MFN1 protein expression was significantly reduced in the liver of NAFLD mice [55,56]. The gene discussed is MFN2; the disease is metabolic dysfunction-associated steatotic liver disease.